Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
The RNA interference (RNAi) pathway possesses immense potential in silencing any gene in human cells. Small interfering RNA (siRNA) can efficiently trigger RNAi silencing of specific genes. FDA Approval of siRNA therapeutics in recent years garnered a new hope in siRNA therapeutics. However, their t...
Sábháilte in:
Príomhchruthaitheoirí: | Muhammad Imran Sajid (Údar), Muhammad Moazzam (Údar), Shun Kato (Údar), Kayley Yeseom Cho (Údar), Rakesh Kumar Tiwari (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
-
Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery
de réir: Mrigank Shekhar Rai, et al.
Foilsithe / Cruthaithe: (2024) -
siRNA Therapeutics: From Bench Lab. to Clinics
de réir: Cristina Romero-López, et al.
Foilsithe / Cruthaithe: (2024) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
de réir: Amir Nasrolahi Shirazi, et al.
Foilsithe / Cruthaithe: (2021) -
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
de réir: Muhammad Imran Sajid, et al.
Foilsithe / Cruthaithe: (2022) -
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
de réir: Danielle de Brito e Cunha, et al.
Foilsithe / Cruthaithe: (2022)